BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
40.16%
↑ 119% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-210.53%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 40.16% | +1313.1% |
| 2024 | 2.84% | +108.1% |
| 2023 | -35.10% | +33.9% |
| 2022 | -53.12% | +31.4% |
| 2021 | -77.46% | +91.8% |
| 2020 | -940.74% | -377.2% |
| 2019 | -197.16% | +54.9% |
| 2018 | -437.54% | -95.0% |
| 2017 | -224.38% | -22.7% |
| 2016 | -182.80% | - |